A citation-based method for searching scientific literature

Riming Liu, Yulan Li, Weixin Chen, Jianglin Cong, Zhengfang Zhang, Li Ma, Lina Chu, Hui Xiao, Yanhong Zhang, Yongming Liu, Yimin Xu, Qin Yu, Xin Yang, Chengming Sun. Oncol Lett 2020
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


An overview of doxorubicin formulations in cancer therapy.
Sangeeta Rivankar. J Cancer Res Ther 2014
204
50

Muscarinic receptor subtypes and receptor-coupled phosphatidylinositol hydrolysis in rat bladder smooth muscle.
H Mimata, Y Nomura, A Emoto, J Latifpour, M Wheeler, R M Weiss. Int J Urol 1997
14
50

Muscarinic receptors mediate stimulation of human lung fibroblast proliferation.
Sonja Matthiesen, Amit Bahulayan, Susanne Kempkens, Susanne Haag, Margarita Fuhrmann, Christine Stichnote, Uwe R Juergens, Kurt Racké. Am J Respir Cell Mol Biol 2006
88
50


Somatic and germline mutations in the tumor suppressor gene PARK2 impair PINK1/Parkin-mediated mitophagy in lung cancer cells.
Zeng-Li Zhang, Na-Na Wang, Qi-Lian Ma, Yang Chen, Li Yao, Li Zhang, Qiu-Shi Li, Min-Hua Shi, Hong-Feng Wang, Zheng Ying. Acta Pharmacol Sin 2020
15
50


Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity.
L Vermeulen, M Todaro, F de Sousa Mello, M R Sprick, K Kemper, M Perez Alea, D J Richel, G Stassi, J P Medema. Proc Natl Acad Sci U S A 2008
538
50

Resistance to paclitaxel in hepatoma cells is related to static JNK activation and prohibition into entry of mitosis.
Sunyoung Chae, Young Bae Kim, Jong-Soo Lee, Hyeseong Cho. Am J Physiol Gastrointest Liver Physiol 2012
14
50

Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer.
Daniel P Silver, Andrea L Richardson, Aron C Eklund, Zhigang C Wang, Zoltan Szallasi, Qiyuan Li, Nicolai Juul, Chee-Onn Leong, Diana Calogrias, Ayodele Buraimoh,[...]. J Clin Oncol 2010
660
50

A review of systematic reviews of the cost-effectiveness of hormone therapy, chemotherapy, and targeted therapy for breast cancer.
Vakaramoko Diaby, Rima Tawk, Vassiki Sanogo, Hong Xiao, Alberto J Montero. Breast Cancer Res Treat 2015
61
50

Activation of muscarinic cholinergic receptors induces MCF-7 cells proliferation and angiogenesis by stimulating nitric oxide synthase activity.
Gabriel L Fiszman, María C Middonno, Eulalia de la Torre, Mariana Farina, Alejandro J Español, María E Sales. Cancer Biol Ther 2007
32
50

Muscarinic cholinergic signaling in cervical cancer cells affects cell motility via ERK1/2 signaling.
Erinn A Parnell, Itzel E Calleja-Macias, Mina Kalantari, Sergei A Grando, Hans-Ulrich Bernard. Life Sci 2012
17
50

Differential cardioprotective/cardiotoxic effects mediated by beta-adrenergic receptor subtypes.
Daniel Bernstein, Giovanni Fajardo, Mingming Zhao, Takashi Urashima, Jennifer Powers, Gerald Berry, Brian K Kobilka. Am J Physiol Heart Circ Physiol 2005
72
50

BRCA1 downregulation leads to premature inactivation of spindle checkpoint and confers paclitaxel resistance.
C Chabalier, C Lamare, C Racca, M Privat, A Valette, F Larminat. Cell Cycle 2006
118
50

Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer.
Rui Kang, Yangchun Xie, Qiuhong Zhang, Wen Hou, Qingping Jiang, Shan Zhu, Jinbao Liu, Dexing Zeng, Haichao Wang, David L Bartlett,[...]. Cell Res 2017
68
50



Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial.
Daniel V T Catenacci, Yoon-Koo Kang, Haeseong Park, Hope E Uronis, Keun-Wook Lee, Matthew C H Ng, Peter C Enzinger, Se Hoon Park, Philip J Gold, Jill Lacy,[...]. Lancet Oncol 2020
39
50

Drug resistance in lung cancer.
K Nishio, T Nakamura, Y Koh, T Suzuki, H Fukumoto, N Saijo. Curr Opin Oncol 1999
47
50

Design and characterization of PEG-derivatized vitamin E as a nanomicellar formulation for delivery of paclitaxel.
Jianqin Lu, Yixian Huang, Wenchen Zhao, Yichao Chen, Jiang Li, Xiang Gao, Raman Venkataramanan, Song Li. Mol Pharm 2013
43
50

ABC Transporter-Mediated Multidrug-Resistant Cancer.
Haneen Amawi, Hong-May Sim, Amit K Tiwari, Suresh V Ambudkar, Suneet Shukla. Adv Exp Med Biol 2019
57
50



Immunoglobulin g from breast cancer patients regulates MCF-7 cells migration and MMP-9 activity by stimulating muscarinic acetylcholine receptors.
Laura T Pelegrina, María Gabriela Lombardi, Gabriel L Fiszman, María E Azar, Carlos Cresta Morgado, María E Sales. J Clin Immunol 2013
16
50

Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer.
Elizabeth Alli, Judy Bash-Babula, Jin-Ming Yang, William N Hait. Cancer Res 2002
159
50

Molecular avenues in targeted doxorubicin cancer therapy.
Sayantani Roychoudhury, Ajay Kumar, Devyani Bhatkar, Nilesh Kumar Sharma. Future Oncol 2020
7
50


Current status of paclitaxel in the treatment of breast cancer.
J A O'Shaughnessy, K H Cowan. Breast Cancer Res Treat 1995
26
50

Human keratinocytes synthesize, secrete, and degrade acetylcholine.
S A Grando, D A Kist, M Qi, M V Dahl. J Invest Dermatol 1993
206
50

Growth Factor-Independent 1 Is a Tumor Suppressor Gene in Colorectal Cancer.
Min-Shan Chen, Yuan-Hung Lo, Xi Chen, Christopher S Williams, Jessica M Donnelly, Zachary K Criss, Shreena Patel, Joann M Butkus, Julien Dubrulle, Milton J Finegold,[...]. Mol Cancer Res 2019
11
50

Mechanisms of doxorubicin resistance in hepatocellular carcinoma.
Josiah Cox, Steven Weinman. Hepat Oncol 2016
60
50

MicroRNA Profile in Response to Doxorubicin Treatment in Breast Cancer.
Eduardo Tormo, Begoña Pineda, Eva Serna, Alba Guijarro, Gloria Ribas, Jaume Fores, Enrique Chirivella, Joan Climent, Ana Lluch, Pilar Eroles. J Cell Biochem 2015
24
50


SOX7 Target Genes and Their Contribution to Its Tumor Suppressive Function.
Yumeng Zhang, Daniel B Stovall, Meimei Wan, Qiang Zhang, Jeff W Chou, Dangdang Li, Guangchao Sui. Int J Mol Sci 2018
14
50



Myocet (liposome-encapsulated doxorubicin citrate): a new approach in breast cancer therapy.
Gerald Batist, Jeremy Barton, Philip Chaikin, Christine Swenson, Lauri Welles. Expert Opin Pharmacother 2002
67
50


Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer.
Aleix Prat, Joel S Parker, Olga Karginova, Cheng Fan, Chad Livasy, Jason I Herschkowitz, Xiaping He, Charles M Perou. Breast Cancer Res 2010
50

A study of the value of p53, HER2, and Bcl-2 in the prediction of response to doxorubicin and paclitaxel as single agents in metastatic breast cancer: a companion study to EORTC 10923.
A Hamilton, D Larsimont, R Paridaens, M Drijkoningen, M van de Vijver, P Bruning, A Hanby, S Houston, I Treilleux, J P Guastalla,[...]. Clin Breast Cancer 2000
38
50

G-Protein Coupled Estrogen Receptor in Breast Cancer.
Li-Han Hsu, Nei-Min Chu, Yung-Feng Lin, Shu-Huei Kao. Int J Mol Sci 2019
28
50

Effect of low dose metronomic therapy on MCF-7 tumor cells growth and angiogenesis. Role of muscarinic acetylcholine receptors.
A R Salem, P Martínez Pulido, F Sanchez, Y Sanchez, A J Español, M E Sales. Int Immunopharmacol 2020
4
50

Classifying Melanoma by TERT Promoter Mutational Status.
Michael Shaughnessy, Ching-Ni Njauw, Mykyta Artomov, Hensin Tsao. J Invest Dermatol 2020
6
50

Cingulate cortex in Parkinson's disease.
Brent A Vogt. Handb Clin Neurol 2019
8
50


TERT Promoter Mutation as a Potential Predictive Biomarker in BCG-Treated Bladder Cancer Patients.
Rui Batista, Luís Lima, João Vinagre, Vasco Pinto, Joana Lyra, Valdemar Máximo, Lúcio Santos, Paula Soares. Int J Mol Sci 2020
14
50

Topoisomerases as anticancer targets.
Justine L Delgado, Chao-Ming Hsieh, Nei-Li Chan, Hiroshi Hiasa. Biochem J 2018
133
50

Clinical outcomes and prognostic factors in patients with stage II-III breast cancer treated with neoadjuvant chemotherapy followed by surgery and postmastectomy radiation therapy in the modern treatment era.
Naomi Nakajima, Masahiko Oguchi, Yasuko Kumai, Masahiro Yoshida, Hirotaka Inoda, Yasuo Yoshioka, Takuji Iwase, Yoshinori Ito, Futoshi Akiyama, Shinji Ohno. Adv Radiat Oncol 2018
3
50

G Protein-Coupled Receptors (GPCRs)-Mediated Calcium Signaling in Ovarian Cancer: Focus on GPCRs activated by Neurotransmitters and Inflammation-Associated Molecules.
Dragoș-Valentin Predescu, Sanda Maria Crețoiu, Dragoș Crețoiu, Luciana Alexandra Pavelescu, Nicolae Suciu, Beatrice Mihaela Radu, Silviu-Cristian Voinea. Int J Mol Sci 2019
17
50

Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer.
J M Nabholtz, K Gelmon, M Bontenbal, M Spielmann, G Catimel, P Conte, U Klaassen, M Namer, J Bonneterre, P Fumoleau,[...]. J Clin Oncol 1996
339
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.